0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Ivosidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-35M2614
Home | Market Reports | Health| Pharmacy
COVID 19 Impact on Ivosidenib Market Global Research Reports 2020 2021
BUY CHAPTERS

Ivosidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35M2614
Report
September 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ivosidenib - Market Size

The global market for Ivosidenib was estimated to be worth US$ 175.3 million in 2023 and is forecast to a readjusted size of US$ 238.5 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Ivosidenib - Market

Ivosidenib - Market

Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ivosidenib, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ivosidenib by region & country, by Type, and by Application.
The Ivosidenib market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivosidenib.
Market Segmentation

Scope of Ivosidenib - Market Report

Report Metric Details
Report Name Ivosidenib - Market
Forecasted market size in 2030 US$ 238.5 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
  • 60 Tablets
  • 30 Tablets
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Servier Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Ivosidenib in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Ivosidenib - Market size in 2030?

Ans: The Ivosidenib - Market size in 2030 will be US$ 238.5 million.

Who are the main players in the Ivosidenib - Market report?

Ans: The main players in the Ivosidenib - Market are Servier Pharmaceuticals

What are the Application segmentation covered in the Ivosidenib - Market report?

Ans: The Applications covered in the Ivosidenib - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Ivosidenib - Market report?

Ans: The Types covered in the Ivosidenib - Market report are 60 Tablets, 30 Tablets

Recommended Reports

Cancer Therapeutics

Targeted Inhibitors

Hematology & Immunotherapy

1 Market Overview
1.1 Ivosidenib Product Introduction
1.2 Global Ivosidenib Market Size Forecast
1.2.1 Global Ivosidenib Sales Value (2019-2030)
1.2.2 Global Ivosidenib Sales Volume (2019-2030)
1.2.3 Global Ivosidenib Sales Price (2019-2030)
1.3 Ivosidenib Market Trends & Drivers
1.3.1 Ivosidenib Industry Trends
1.3.2 Ivosidenib Market Drivers & Opportunity
1.3.3 Ivosidenib Market Challenges
1.3.4 Ivosidenib Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ivosidenib Players Revenue Ranking (2023)
2.2 Global Ivosidenib Revenue by Company (2019-2024)
2.3 Global Ivosidenib Players Sales Volume Ranking (2023)
2.4 Global Ivosidenib Sales Volume by Company Players (2019-2024)
2.5 Global Ivosidenib Average Price by Company (2019-2024)
2.6 Key Manufacturers Ivosidenib Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ivosidenib Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ivosidenib
2.9 Ivosidenib Market Competitive Analysis
2.9.1 Ivosidenib Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ivosidenib Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ivosidenib as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 60 Tablets
3.1.2 30 Tablets
3.2 Global Ivosidenib Sales Value by Type
3.2.1 Global Ivosidenib Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ivosidenib Sales Value, by Type (2019-2030)
3.2.3 Global Ivosidenib Sales Value, by Type (%) (2019-2030)
3.3 Global Ivosidenib Sales Volume by Type
3.3.1 Global Ivosidenib Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ivosidenib Sales Volume, by Type (2019-2030)
3.3.3 Global Ivosidenib Sales Volume, by Type (%) (2019-2030)
3.4 Global Ivosidenib Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Ivosidenib Sales Value by Application
4.2.1 Global Ivosidenib Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ivosidenib Sales Value, by Application (2019-2030)
4.2.3 Global Ivosidenib Sales Value, by Application (%) (2019-2030)
4.3 Global Ivosidenib Sales Volume by Application
4.3.1 Global Ivosidenib Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ivosidenib Sales Volume, by Application (2019-2030)
4.3.3 Global Ivosidenib Sales Volume, by Application (%) (2019-2030)
4.4 Global Ivosidenib Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ivosidenib Sales Value by Region
5.1.1 Global Ivosidenib Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ivosidenib Sales Value by Region (2019-2024)
5.1.3 Global Ivosidenib Sales Value by Region (2025-2030)
5.1.4 Global Ivosidenib Sales Value by Region (%), (2019-2030)
5.2 Global Ivosidenib Sales Volume by Region
5.2.1 Global Ivosidenib Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ivosidenib Sales Volume by Region (2019-2024)
5.2.3 Global Ivosidenib Sales Volume by Region (2025-2030)
5.2.4 Global Ivosidenib Sales Volume by Region (%), (2019-2030)
5.3 Global Ivosidenib Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ivosidenib Sales Value, 2019-2030
5.4.2 North America Ivosidenib Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ivosidenib Sales Value, 2019-2030
5.5.2 Europe Ivosidenib Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ivosidenib Sales Value, 2019-2030
5.6.2 Asia Pacific Ivosidenib Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ivosidenib Sales Value, 2019-2030
5.7.2 South America Ivosidenib Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ivosidenib Sales Value, 2019-2030
5.8.2 Middle East & Africa Ivosidenib Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ivosidenib Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ivosidenib Sales Value
6.2.1 Key Countries/Regions Ivosidenib Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ivosidenib Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ivosidenib Sales Value, 2019-2030
6.3.2 United States Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ivosidenib Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ivosidenib Sales Value, 2019-2030
6.4.2 Europe Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ivosidenib Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ivosidenib Sales Value, 2019-2030
6.5.2 China Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ivosidenib Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ivosidenib Sales Value, 2019-2030
6.6.2 Japan Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ivosidenib Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ivosidenib Sales Value, 2019-2030
6.7.2 South Korea Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ivosidenib Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ivosidenib Sales Value, 2019-2030
6.8.2 Southeast Asia Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ivosidenib Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ivosidenib Sales Value, 2019-2030
6.9.2 India Ivosidenib Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ivosidenib Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Servier Pharmaceuticals
7.1.1 Servier Pharmaceuticals Company Information
7.1.2 Servier Pharmaceuticals Introduction and Business Overview
7.1.3 Servier Pharmaceuticals Ivosidenib Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Servier Pharmaceuticals Ivosidenib Product Offerings
7.1.5 Servier Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Ivosidenib Industrial Chain
8.2 Ivosidenib Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ivosidenib Sales Model
8.5.2 Sales Channel
8.5.3 Ivosidenib Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Ivosidenib Market Trends
    Table 2. Ivosidenib Market Drivers & Opportunity
    Table 3. Ivosidenib Market Challenges
    Table 4. Ivosidenib Market Restraints
    Table 5. Global Ivosidenib Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Ivosidenib Revenue Market Share by Company (2019-2024)
    Table 7. Global Ivosidenib Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Ivosidenib Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Ivosidenib Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Ivosidenib Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Ivosidenib Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Ivosidenib
    Table 13. Global Ivosidenib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ivosidenib as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ivosidenib Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Ivosidenib Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Ivosidenib Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Ivosidenib Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Ivosidenib Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Ivosidenib Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Ivosidenib Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Ivosidenib Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Ivosidenib Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Ivosidenib Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Ivosidenib Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Ivosidenib Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Ivosidenib Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Ivosidenib Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Ivosidenib Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Ivosidenib Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Ivosidenib Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Ivosidenib Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Ivosidenib Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Ivosidenib Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Ivosidenib Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Ivosidenib Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Ivosidenib Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Ivosidenib Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Ivosidenib Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Ivosidenib Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Ivosidenib Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Ivosidenib Sales Value by Region (2019-2024) & (%)
    Table 44. Global Ivosidenib Sales Value by Region (2025-2030) & (%)
    Table 45. Global Ivosidenib Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Ivosidenib Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Ivosidenib Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Ivosidenib Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Ivosidenib Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Ivosidenib Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Ivosidenib Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Ivosidenib Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Ivosidenib Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Ivosidenib Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Ivosidenib Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Ivosidenib Sales Volume, (2025-2030) & (Units)
    Table 57. Servier Pharmaceuticals Company Information
    Table 58. Servier Pharmaceuticals Introduction and Business Overview
    Table 59. Servier Pharmaceuticals Ivosidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Servier Pharmaceuticals Ivosidenib Product Offerings
    Table 61. Servier Pharmaceuticals Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Ivosidenib Downstream Customers
    Table 65. Ivosidenib Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ivosidenib Product Picture
    Figure 2. Global Ivosidenib Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Ivosidenib Sales Volume (2019-2030) & (Units)
    Figure 5. Global Ivosidenib Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Ivosidenib Report Years Considered
    Figure 7. Global Ivosidenib Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Ivosidenib Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ivosidenib Revenue in 2023
    Figure 10. Ivosidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 60 Tablets Picture
    Figure 12. 30 Tablets Picture
    Figure 13. Global Ivosidenib Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Ivosidenib Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Ivosidenib Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global Ivosidenib Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Ivosidenib Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Pharmacy
    Figure 20. Global Ivosidenib Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Ivosidenib Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Ivosidenib Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 23. Global Ivosidenib Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Ivosidenib Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Ivosidenib Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Ivosidenib Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Ivosidenib Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Ivosidenib Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Ivosidenib Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Ivosidenib Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Ivosidenib Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Ivosidenib Sales Volume (%), (2019-2030)
    Figure 37. United States Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Ivosidenib Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Ivosidenib Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Ivosidenib Sales Value by Application (%), 2023 VS 2030
    Figure 58. Ivosidenib Industrial Chain
    Figure 59. Ivosidenib Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart